Tandem Diabetes Care, Inc. (TNDM)
USD 16.43
(-6.96%)
USD 16.43
(-6.96%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 952.65 Million USD | -9.51% |
| 2022 | 1.05 Billion USD | 16.31% |
| 2021 | 905.13 Million USD | 26.34% |
| 2020 | 716.41 Million USD | 119.69% |
| 2019 | 326.11 Million USD | 58.08% |
| 2018 | 206.29 Million USD | 116.36% |
| 2017 | 95.34 Million USD | -15.17% |
| 2016 | 112.39 Million USD | -10.17% |
| 2015 | 125.11 Million USD | 17.52% |
| 2014 | 106.46 Million USD | -34.37% |
| 2013 | 162.21 Million USD | 307.4% |
| 2012 | 39.81 Million USD | 184.86% |
| 2011 | 13.97 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 941.04 Million USD | -1.22% |
| 2024 Q2 | 937.5 Million USD | -0.38% |
| 2023 Q4 | 952.65 Million USD | 1.36% |
| 2023 Q3 | 939.9 Million USD | -0.71% |
| 2023 FY | 952.65 Million USD | -9.51% |
| 2023 Q1 | 954.14 Million USD | -9.37% |
| 2023 Q2 | 946.67 Million USD | -0.78% |
| 2022 FY | 1.05 Billion USD | 16.31% |
| 2022 Q4 | 1.05 Billion USD | 0.5% |
| 2022 Q1 | 1.01 Billion USD | 12.17% |
| 2022 Q3 | 1.04 Billion USD | 1.06% |
| 2022 Q2 | 1.03 Billion USD | 2.1% |
| 2021 FY | 905.13 Million USD | 26.34% |
| 2021 Q2 | 795.25 Million USD | 5.43% |
| 2021 Q1 | 754.27 Million USD | 5.28% |
| 2021 Q4 | 905.13 Million USD | 6.45% |
| 2021 Q3 | 850.27 Million USD | 6.92% |
| 2020 Q4 | 716.41 Million USD | 6.45% |
| 2020 Q3 | 672.98 Million USD | 9.21% |
| 2020 Q1 | 343.32 Million USD | 5.28% |
| 2020 Q2 | 616.23 Million USD | 79.49% |
| 2020 FY | 716.41 Million USD | 119.69% |
| 2019 Q4 | 326.11 Million USD | 11.43% |
| 2019 Q3 | 292.64 Million USD | 14.73% |
| 2019 FY | 326.11 Million USD | 58.08% |
| 2019 Q1 | 214.69 Million USD | 4.07% |
| 2019 Q2 | 255.08 Million USD | 18.81% |
| 2018 Q3 | 181.6 Million USD | 14.94% |
| 2018 Q4 | 206.29 Million USD | 13.59% |
| 2018 FY | 206.29 Million USD | 116.36% |
| 2018 Q1 | 144.69 Million USD | 51.76% |
| 2018 Q2 | 157.99 Million USD | 9.19% |
| 2017 FY | 95.34 Million USD | -15.17% |
| 2017 Q4 | 95.34 Million USD | 8.38% |
| 2017 Q1 | 112.71 Million USD | 0.29% |
| 2017 Q3 | 87.97 Million USD | -10.72% |
| 2017 Q2 | 98.54 Million USD | -12.57% |
| 2016 Q1 | 120.64 Million USD | -3.58% |
| 2016 FY | 112.39 Million USD | -10.17% |
| 2016 Q4 | 112.39 Million USD | 24.42% |
| 2016 Q3 | 90.33 Million USD | -17.27% |
| 2016 Q2 | 109.19 Million USD | -9.49% |
| 2015 FY | 125.11 Million USD | 17.52% |
| 2015 Q4 | 125.11 Million USD | -2.64% |
| 2015 Q3 | 128.51 Million USD | -9.07% |
| 2015 Q2 | 141.33 Million USD | -8.89% |
| 2015 Q1 | 155.12 Million USD | 45.71% |
| 2014 Q1 | 142.38 Million USD | -12.22% |
| 2014 FY | 106.46 Million USD | -34.37% |
| 2014 Q4 | 106.46 Million USD | -8.67% |
| 2014 Q3 | 116.56 Million USD | -10.35% |
| 2014 Q2 | 130.01 Million USD | -8.69% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q2 | 59.22 Million USD | 0.0% |
| 2013 Q3 | 48.57 Million USD | -17.99% |
| 2013 Q4 | 162.21 Million USD | 233.96% |
| 2013 FY | 162.21 Million USD | 307.4% |
| 2012 FY | 39.81 Million USD | 184.86% |
| 2012 Q4 | 39.81 Million USD | 0.0% |
| 2011 FY | 13.97 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -2937.231% |
| BrainsWay Ltd. | 62.97 Million USD | -1412.828% |
| Cerus Corporation | 197.74 Million USD | -381.754% |
| Envoy Medical, Inc. | 7.64 Million USD | -12369.346% |
| electroCore, Inc. | 16.38 Million USD | -5713.499% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -12285.049% |
| IceCure Medical Ltd | 16.41 Million USD | -5705.35% |
| Inogen, Inc. | 326.19 Million USD | -192.053% |
| OrthoPediatrics Corp. | 449.58 Million USD | -111.897% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -3393.429% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -5646.17% |
| MaxCyte, Inc. | 268.27 Million USD | -255.106% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -11665.111% |
| Nexalin Technology, Inc. | 3.63 Million USD | -26130.177% |
| Orthofix Medical Inc. | 925.31 Million USD | -2.955% |
| PAVmed Inc | 33.11 Million USD | -2776.47% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -564.095% |
| RxSight, Inc. | 182.55 Million USD | -421.861% |
| Sight Sciences, Inc. | 166.65 Million USD | -471.649% |
| SI-BONE, Inc. | 230.42 Million USD | -313.435% |
| TELA Bio, Inc. | 78.04 Million USD | -1120.605% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | -278.178% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -8778.453% |
| Acutus Medical, Inc. | 53.96 Million USD | -1665.489% |
| Talis Biomedical Corporation | 98.34 Million USD | -868.739% |
| Spectral AI, Inc. | 10.69 Million USD | -8810.007% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -335.704% |
| CVRx, Inc. | 115.22 Million USD | -726.752% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -1524.006% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -30480.438% |
| Bioventus Inc. | 810.91 Million USD | -17.48% |
| Venus Concept Inc. | 93.65 Million USD | -917.21% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -3603.238% |
| LivaNova PLC | 2.42 Billion USD | 60.789% |
| 908 Devices Inc. | 202.98 Million USD | -369.334% |
| Alphatec Holdings, Inc. | 805.2 Million USD | -18.312% |
| Nemaura Medical Inc. | 14.56 Million USD | -6441.528% |
| NeuroPace, Inc. | 107.65 Million USD | -784.95% |
| LENSAR, Inc. | 69.58 Million USD | -1269.057% |
| Apyx Medical Corporation | 79.24 Million USD | -1102.244% |
| Cutera, Inc. | 346.29 Million USD | -175.103% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -2167.37% |
| BioSig Technologies, Inc. | 1.79 Million USD | -52884.316% |
| Anika Therapeutics, Inc. | 270.63 Million USD | -252.012% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -2133.089% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 74.811% |
| Axonics, Inc. | 719.92 Million USD | -32.328% |
| Outset Medical, Inc. | 313.8 Million USD | -203.587% |
| IRIDEX Corporation | 34.43 Million USD | -2666.46% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | -135.389% |
| IRadimed Corporation | 92.15 Million USD | -933.744% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -18032.052% |
| INVO Bioscience, Inc. | 20.88 Million USD | -4460.837% |
| Telesis Bio, Inc. | 70.41 Million USD | -1252.996% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -518.198% |
| Varex Imaging Corporation | 1.24 Billion USD | 23.763% |
| Quipt Home Medical Corp. | 247.4 Million USD | -285.055% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -10132.632% |
| Pulmonx Corporation | 178.95 Million USD | -432.357% |
| Dynatronics Corporation | 25.94 Million USD | -3572.465% |
| Modular Medical, Inc. | 13.8 Million USD | -6799.819% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -8780.936% |
| Semler Scientific, Inc. | 78.06 Million USD | -1120.339% |
| InMode Ltd. | 863.28 Million USD | -10.353% |
| Bruker Corporation | 4.24 Billion USD | 77.584% |
| Cytosorbents Corporation | 53.26 Million USD | -1688.672% |
| DexCom, Inc. | 6.26 Billion USD | 84.793% |
| Align Technology, Inc. | 6.08 Billion USD | 84.341% |
| Viveve Medical, Inc. | 25.91 Million USD | -3576.371% |
| ZimVie Inc. | 1.2 Billion USD | 20.964% |
| Movano Inc. | 9.42 Million USD | -10012.069% |
| Cytek Biosciences, Inc. | 497.66 Million USD | -91.424% |
| Nexalin Technology, Inc. | 3.63 Million USD | -26130.177% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -1524.006% |
| Profound Medical Corp. | 43.68 Million USD | -2080.677% |
| Insulet Corporation | 2.58 Billion USD | 63.192% |
| enVVeno Medical Corporation | 48.63 Million USD | -1858.791% |
| Surmodics, Inc. | 185.73 Million USD | -412.918% |
| iCAD, Inc. | 41.41 Million USD | -2200.106% |
| Nuwellis, Inc. | 9.77 Million USD | -9650.85% |
| Biotricity, Inc. | 5.94 Million USD | -15930.929% |
| iRhythm Technologies, Inc. | 433.14 Million USD | -119.94% |
| Aethlon Medical, Inc. | 8.24 Million USD | -11452.996% |
| InspireMD, Inc. | 47.64 Million USD | -1899.576% |
| PAVmed Inc. | 33.11 Million USD | -2776.47% |
| BIOLASE, Inc. | 35.1 Million USD | -2614.048% |
| Beyond Air, Inc. | 56.96 Million USD | -1572.474% |
| FONAR Corporation | 214.24 Million USD | -344.656% |
| AxoGen, Inc. | 196.82 Million USD | -384.008% |
| Vivani Medical, Inc. | 45.79 Million USD | -1980.176% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | -238.497% |
| Inari Medical, Inc. | 674.23 Million USD | -41.295% |
| UFP Technologies, Inc. | 404.13 Million USD | -135.727% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -3971.438% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -9924.694% |
| Tenon Medical, Inc. | 6.34 Million USD | -14914.31% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -10027.118% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -819.131% |
| AdaptHealth Corp. | 4.61 Billion USD | 79.379% |
| Sintx Technologies, Inc. | 15.36 Million USD | -6100.182% |
| NanoVibronix, Inc. | 6.67 Million USD | -14174.168% |
| Quanterix Corporation | 425.01 Million USD | -124.149% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -10132.632% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -1673.146% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 45.438% |
| TransMedics Group, Inc. | 706.04 Million USD | -34.928% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -1407.561% |
| NeuroMetrix, Inc. | 21.42 Million USD | -4346.594% |
| Hyperfine, Inc. | 94.19 Million USD | -911.325% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | -254.621% |
| Biomerica, Inc. | 9.25 Million USD | -10194.554% |
| Bone Biologics Corporation | 3.73 Million USD | -25387.384% |
| AVITA Medical, Inc. | 144.33 Million USD | -560.01% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -19467.668% |
| Silk Road Medical, Inc | 265.3 Million USD | -259.075% |